Suicide Gene Therapy for Oral Squamous Cell Carcinoma
- 692 Downloads
Suicide gene therapy has been tested for the treatment of a variety of cancers, including oral cancer. Among the various suicide gene therapy approaches that have been reported, the Herpes Simplex Virus thymidine kinase (HSV-tk)/ganciclovir (GCV) system is one of the most extensively studied systems, holding great promise in cancer therapy. In this chapter, we describe methods to use the HSV-tk/GCV system to achieve antitumor activity, both in cultured oral cancer cells and in orthotopic and subcutaneous murine models of oral squamous cell carcinoma, using ligand-associated lipoplexes for enhancing therapeutic delivery.
Key wordsCationic liposomes Lipoplexes HSV-tk/GCV suicide gene therapy Oral carcinoma Modulation of gap junctions Antitumor activity
- 13.Neves SS, Sarmento-Ribeiro AB, Simões S, Pedroso de Lima MC (2006) Transfection of oral cancer cells mediated by transferrin-associated lipoplexes: mechanisms of cell death induced by herpes simplex virus thymidine kinase/ganciclovir therapy. Biochim Biophys Acta 1758:1703–1712CrossRefGoogle Scholar
- 14.Neves S, Faneca H, Bertin S, Konopka K, Düzgüneş N, Pierrefite-Carle V et al (2008) Transferrin lipoplex-mediated suicide gene therapy of oral squamous cell carcinoma in an immunocompetent murine model and mechanisms involved in the antitumoral response. Cancer Gene Ther 16:91–101CrossRefGoogle Scholar